Porphyria cutanea tarda is a rare genetic disorder characterized by photosensitivity, blisters, and skin fragility, caused by a deficiency in the enzyme uroporphyrinogen decarboxylase.
Hyperbaric oxygen therapy may alleviate Porphyria cutanea tarda symptoms by increasing oxygen supply and reducing inflammation, ultimately promoting tissue healing and skin regeneration.